- Generic name
- Ondansetron
- Strength
- 8 mg
- Dosage form
- Tablet
- Manufactured by
- Rephco Pharmaceuticals Ltd.
Avoma Tablet
About Avoma 8 mg Tablet
The tablet Avoma contains Ondansetron and is made by Rephco Pharmaceuticals Ltd. Avoma tablet is used to prevent nausea and vomiting caused by cancer chemotherapy and radiotherapy.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Avoma 8 mg Tablet?
Avoma 8 mg is a tablet product of Rephco Pharmaceuticals Ltd. that contains Ondansetron. Doctors use it to help control nausea and vomiting linked to certain cancer chemotherapy, radiotherapy and surgery. It is used to prevent nausea and vomiting caused by cancer chemotherapy, radiotherapy, and surgery. Ask your doctor or pharmacist if you are unsure about it.
Uses of Avoma
Avoma tablet is used to prevent nausea and vomiting caused by cancer chemotherapy and radiotherapy. It does not treat other causes of vomiting, so the doctor should be told about the person's symptoms and medical history. It belongs to a group of medicines called anti-emetics, which help control the vomiting reflex. Ask your doctor whether it is right for your condition.
How to use Avoma
Avoma 8 mg tablet is taken by mouth. Swallow the tablet with water. Take Avoma 8 mg tablet exactly as your doctor tells you. The doctor will decide the dose and course of Avoma for you. The doctor decides the dose and the course, including how it fits around chemotherapy, radiotherapy or surgery.
Side effects of Avoma
Tell the doctor about any side effect that worries you. Do not try to treat side effects yourself without medical advice. Commonly reported ones include headache, constipation and diarrhoea, but these are usually mild or moderate.
Safety and precautions
Do not take Avoma if you have had an allergic reaction to Ondansetron or any ingredient in the tablet. There are no adequate studies in pregnant women, so ask your doctor if you are pregnant or planning pregnancy. There is limited information about its use in pregnancy and breastfeeding; ask your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Tell your doctor if you have had allergic reactions to similar medicines, or if you have had stomach or intestinal surgery, as this medicine may hide certain conditions.
Frequently asked questions
What does Avoma treat?
Avoma tablet is used to prevent nausea and vomiting caused by cancer chemotherapy and radiotherapy. It does not treat other causes of vomiting, so the doctor should be told about the person's symptoms and medical history.
How do I use Avoma correctly?
Avoma 8 mg tablet is taken by mouth. Swallow the tablet with water.
Can Avoma cause side effects?
Tell the doctor about any side effect that worries you. Do not try to treat side effects yourself without medical advice.
Who should be careful with Avoma?
Do not take Avoma if you have had an allergic reaction to Ondansetron or any ingredient in the tablet. There are no adequate studies in pregnant women, so ask your doctor if you are pregnant or planning pregnancy.
Also available as
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.